Prevalence and risk factors of eligibility to anti-osteoporosis medication in a cohort of men ≥ 50 years and post-menopausal women who had already experienced bariatric surgery
Endocr Connect. 2025 Sep 23:EC-25-0368. doi: 10.1530/EC-25-0368. Online ahead of print. ABSTRACT The 2022 recommendations of the European Calcified Tissue […]
